Diana Mckenzie - Feb 17, 2023 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Director
Signature
/s/ Timothy Bensley, as Attorney-in-Fact
Stock symbol
AGL
Transactions as of
Feb 17, 2023
Transactions value $
$0
Form type
4
Date filed
2/22/2023, 04:20 PM
Previous filing
Jan 18, 2023
Next filing
Mar 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Award $0 +1.08K $0.00 1.08K Feb 17, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Award $0 +11.1K $0.00 11.1K Feb 17, 2023 Common Stock 11.1K $22.79 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units that vest in full on February 17, 2024, subject to continued service as a director.
F2 Options that vest in three equal installments on each anniversary of February 17, 2023, subject to continued service as a director.